Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: Maraviroc, raltegravir, etravirine

Silvia Nozza, Laura Galli, Alba Bigoloni, Gianotti Nicola, Manuela Pogliaghi, Francesca Cossarini, Stefania Salpietro, Andrea Galli, Liviana Della Torre, Giuseppe Tambussi, Adriano Lazzarin, Antonella Castagna

Research output: Contribution to journalArticle

Original languageEnglish
JournalJournal of Acquired Immune Deficiency Syndromes
Volume56
Issue number4
DOIs
Publication statusPublished - Apr 1 2011

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this